A recent lawsuit filed by Myriad Genetics involving the alleged infringement of their controversial breast cancer screening tool has included the prestigious Toronto SickKids hospital as a co-plaintiff. This lawsuit…
Category: US-Canada Relations
in Access to Medicines, Blogs, Canada, European Union, IP, Patents, Pharmaceutical Drugs, Regulatory Policy, Uncategorized, US, US-Canada Relations0by Editor
1043
Time for a Change? Fraser Institute Urges Canada to Strengthen its Pharmaceutical IP Laws
A little over a week ago, the Fraser Institute, a prominent and independent Canadian public policy think tank, released a report calling for a strengthening of intellectual property protection for…
in Canada, European Union, Infringement, IP, Jurisdiction, Patentability, Patents, Pharmaceutical Drugs, Regulatory Policy, Supreme Court of Canada, UK, UK, US, US-Canada Relations0by Editor
1461
Sitting This One Out: SCC Refuses to Clarify “Promise of a Patent” Doctrine
Last month, the Supreme Court of Canada (SCC) denied leave to appeal in the case Eli Lilly Canada Inc v Novopharm Ltd, passing on an opportunity to clarify the controversial…
in Copyright, Copyright Reform, European Union, IP, IP Reform, Patents, Pharmaceutical Drugs, Supreme Court of Canada, Trademarks, US, US-Canada Relations, WIPO0by Editor
1310
A Cautionary Kudos: Canada Moves Up on USTR IP Watch List
Earlier this month, the United States Trade Representative (USTR) released its annual “Special 301 Report,” which evaluates the intellectual property rights (IPR) protection and enforcement of its trading partners. Over…
in Canada, Cross Border Issues, IP Reform, Patent Practice, Patentability, Patents, Regulatory Policy, Smartphones, Tech Transfer, Technology, Uncategorized, US, US-Canada Relations5by Editor
836
Avoiding Poison Apples and Tending to Blackberries: Did Canada’s 1989 Shift To First-To-File Nip Small-Time Innovation In the Bud?
New legal research from the University of Pennsylvania Law School suggests so. The aim of the study, according to Professors David S. Abrams and R. Polk Wagner, is to empirically predict…
in Access to Medicines, Canada, Copyright, Infringement, IP, Music Industry, Patents, Privacy, US, US-Canada Relations0by Editor
584
Desperate for a Partnership?
Canada has been lobbying to enter the Trans-Pacific Partnership (TPP), and its efforts have seemingly paid off with an exclusive invite to the secretive nine-member club on June 19, 2012.…